Li Jixin, Yang Caili, Wang Yan
Department of Neurology, The First People's Hospital of Linhai, Taizhou, Zhejiang 317000, P.R. China.
Department of Neurology, The Second People's Hospital of Linhai, Taizhou, Zhejiang 317016, P.R. China.
Mol Med Rep. 2021 Jul;24(1). doi: 10.3892/mmr.2021.12158. Epub 2021 May 20.
Following the publication of this article, the authors have realized that the two affiliation addresses in the paper were written incorrectly: "The First People's Hospital" and "The Second People's Hospital" should have appeared as "The First People's Hospital of Linhai" and "The Second People's Hospital of Linhai", respectively. Therefore, the author affiliations and addresses in this paper should have appeared as follows: Jixin Li1, Caili Yang1 and Yan Wang2. 1Department of Neurology, The First People's Hospital of Linhai, Taizhou, Zhejiang 317000; 2Department of Neurology, The Second People's Hospital of Linhai, Taizhou, Zhejiang 317016, P.R. China. The authors regret these errors in the presentation of the affiliation addresses, and apologize for any inconvenience caused.[the original article was published in Molecular Medicine Reports 23: Article no. 165, 2021; DOI: 10.3892/mmr.2020.11804].
在本文发表后,作者意识到论文中的两个单位地址书写有误:“临海市第一人民医院”和“临海市第二人民医院”应分别写为“浙江省台州市临海市第一人民医院”和“浙江省台州市临海市第二人民医院”。因此,本文作者的单位和地址应如下所示:李吉新1、杨彩丽1、王艳2。1浙江省台州市临海市第一人民医院神经内科,邮编317000;2浙江省台州市临海市第二人民医院神经内科,邮编317016,中华人民共和国。作者对单位地址表述中的这些错误表示遗憾,并为由此造成的任何不便表示歉意。[原文发表于《分子医学报告》23卷:第165号文章,2021年;DOI:10.3892/mmr.2020.11804]